Skip to main content
. 2012 Oct 25;35(12):E40–E45. doi: 10.1002/clc.22069

Table 3.

Adverse Events

Variable Dabigatran (n = 122) Warfarin (n = 122) P Value
Dyspepsia 24 (19.7%) 10 (8.2%) 0.010a
Dizziness 20 (16.4%) 11 (9.0%) 0.084
Dyspnea 14 (11.5%) 13 (10.7%) 0.838
Chest pain 14 (11.5%) 7 (5.7%) 0.110
Peripheral edema 10 (8.2%) 27 (22.1%) 0.002a
Insomnia 3 (2.5%) 0 (0.0%) 0.123
Constipation 2 (1.6%) 0 (0.0%) 0.249
Poor appetite 2 (1.6%) 0 (0.0%) 0.249
a

denoted P ≤ 0.05.